Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study

Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study

Abstract Sputnik-V (Gam-COVID-Vac) is a heterologous, recombinant adenoviral (rAdv) vector-based, COVID-19 vaccine now used in > 70 countries. Yet there is a shortage of data on this vaccine's performance in diverse populations. Here, we performed a prospective cohort study to assess the rea...

Full description

Bibliographic Details
Main Authors: Sergey Yegorov, Irina Kadyrova, Baurzhan Negmetzhanov, Yevgeniya Kolesnikova, Svetlana Kolesnichenko, Ilya Korshukov, Yeldar Baiken, Bakhyt Matkarimov, Matthew S. Miller, Gonzalo H. Hortelano, Dmitriy Babenko
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-17514-3

Internet

https://doi.org/10.1038/s41598-022-17514-3

Similar Items